Impact of spot charge inaccuracies in IMPT treatments
|
|
- Michael Foster
- 5 years ago
- Views:
Transcription
1 Impact of spot charge inaccuracies in IMPT treatments Aafke C. Kraan a) Applications of Detectors and Accelerators to Medicine (ADAM SA), Geneva, Switzerland Nicolas Depauw and Ben Clasie Department of Physics, Massachusetts General Hospital, Boston, MA, USA Marina Giunta Applications of Detectors and Accelerators to Medicine (ADAM SA), Geneva, Switzerland Tom Madden and Hanne M. Kooy Department of Physics, Massachusetts General Hospital, Boston, MA, USA (Received 2 February 27; revised 8 April 27; accepted for publication 28 May 27; published 4 July 27) Background: Spot charge is one parameter of pencil-beam scanning dose delivery system whose accuracy is typically high but whose required value has not been investigated. In this work we quantify the dose impact of spot charge inaccuracies on the dose distribution in patients. Knowing the effect of charge errors is relevant for conventional proton machines, as well as for new generation proton machines, where ensuring accurate charge may be challenging. Methods: Through perturbation of spot charge in treatment plans for seven patients and a phantom, we evaluated the dose impact of absolute (up to 59 6 protons) and relative (up to %) charge errors. We investigated the dependence on beam width by studying scenarios with small, medium and large beam sizes. Treatment plan statistics included the passing rate, dose-volume-histograms and dose differences. Results: The allowable absolute charge error for small spot plans was about 29 6 protons. Larger limits would be allowed if larger spots were used. For relative errors, the maximum allowable error size for small, medium and large spots was about %, 8% and 6% for small, medium and large spots, respectively. Conclusions: Dose distributions turned out to be surprisingly robust against random spot charge perturbation. Our study suggests that ensuring spot charge errors as small as 2% as is commonly aimed at in conventional proton therapy machines, is clinically not strictly needed. 27 American Association of Physicists in Medicine [ Key words: dose delivery, IMPT, new technologies, spot charge, uncertainty. INTRODUCTION Intensity-modulated proton therapy (IMPT) delivers dose to the patient by combining the dose from numerous small proton beams (spots), combined in several fields, each with a certain energy, position, and number of protons. It is generally known that patient setup uncertainties, range uncertainties, and changes in patient anatomy can significantly change the dose distribution. Mitigation strategies include accurate patient setup methods, robust plan optimization, and adaptive proton therapy. Typically, the error on the spot charge or monitoring units, i.e., the number of protons per spot given to the patient in a treatment, is not considered. Current IMPT beam production systems based on cyclotrons, synchrotrons, or synchrocyclotrons have a spot charge uncertainty of about 2% which is no source of concern.,2 New-generation ion beam production systems may have spot charge errors significantly larger than current systems which may produce unacceptable dose deviations. Linear accelerators, for instance, produce protons in pulses. In the current systems, the beam is effectively DC and beam current monitoring and counting devices stop the beam as soon as the desired number of proton is reached. In pulsed machines, the beam pulse has a very short width (on the order of ls) and is produced in a duty cycle of typically a few hundred Hz. In this case the pulse charge is only controlled in the most upstream component of the accelerator complex: the proton source. Realizing fast changes in current intensity and/or pulse length, as required to modulate the pulse charge in IMPT, is thus challenging. Whether spot charge accuracy at the percent level is achievable is yet to be seen. Possible mitigation techniques to decrease the statistical error may be to rescan the tumor, or part of the tumor volume, several times which increases the treatment time. Apart from new-generation proton machines, knowing the effect of erroneous charge is important for conventional machines too. The goal of this study was to quantify the dose impact of charge uncertainties in patients through the analysis of comparative perturbation of the spot charge in treatment plans for different sites. In other words: what is the dose effect from possible charge errors and what charge errors are clinically tolerable without applying mitigation strategies? Moreover, 92 Med. Phys. 44 (8), August /27/44(8)/92/9 27 American Association of Physicists in Medicine 92
2 924 Kraan et al.: Spot charge inaccuracies in IMPT 924 we identify which factors contribute to the sensitivity of dose to charge uncertainties, and we propose charge uncertainty mitigation strategies. 2. METHODS AND MATERIALS 2.A. Charge error simulation We define two independent sources of charge errors: DQ ¼ Gð; Þ () Gð; ÞQ S where G(,) is a Gaussian centered on with a r =, is an absolute charge error magnitude, e is a relative error value of the spot charge Q S expressed in %. We separately simulated values of ¼ :5; ; :5; 2; and 5 Mp ( 6 protons) and e = 2, 4, 6,, 6, 22, and %. These values are very large for conventional machines but may not be unrealistic for new-generation proton therapy machines. The random charge error DQ for each spot was added to its spot charge value Q S in a fraction. The nominal, i.e., without any error, fraction dose matrix was D Fx, which is the same for each fraction i. The perturbed fraction spotlist yielded a perturbed fraction dose matrix D Fx;i for fraction i of the total fractions N Fx. We compared the individual fraction doses D Fx;i and the mean dose over all fractions hd Fx i¼ R id Fx;i (2) N Fx with D Fx. We used a set of seven patients and one phantom, irradiated to individual prescription dose values D T, delivered over N fx fractions. The patients differ in target volume, number of fractions, dose per fraction D Rx, and number of fields N F per fraction. The latter affected the average spot charge which, in turn, affects the consequences of charge errors, especially for absolute charge errors. The Astroid treatment planning system developed at MGH 4 6 was used for plan creation. For each patient, plans were created using three different spot widths (r = 2.5, 5, and mm at high energy at the iso-center in air, also referred to as small, medium and large spots, respectively. The longitudinal distance between the spots was equal to the distal Bragg peak width at % of its maximum value, w%. The lateral spacing, d, between the spots was.5r. We aimed at V95% > 98% and V7% < 5%. We allowed more flexibility for the spinal sarcoma and cardiac patient, in order to better spare the organs-at-risk. All plans were clinically validated. We repeated the simulation N Fx times for each error value, for a total of about simulations: 8 (7 patients + phantom) 9 (beam widths) 9 4 (nominal plan + 6 absolute + 7 relative error values) N Fx, with the latter depending on the patient, see Table I. 2.B. Analysis We analyzed differences between fractions and over fractions based on a comparison of the perturbed dose matrix D Fx;i and hd Fx i, respectively, against the nominal dose matrix D Fx. The analysis was restricted to voxels v above a particular dose threshold T = % of D Fx, to identify voxels within and close to the target. This threshold was chosen to avoid that the plan statistics are influenced by the size of the dose matrix and to avoid statistics to be dominated by a large low-dose region. We analyzed the following plan statistics. The dose volume histograms (DVH) and associated dose parameters like V95% and V7%. We considered V95% > 98% and V7% < % acceptable for perfraction results, and V95% > 99% and V7% < 5% acceptable for fraction-averaged results. TABLE I. Summary of patients and the water phantom studied: site, target names, target volumes, prescribed dose D T, number of fractions N fx, prescribed dose per fraction D Rx, number of fields N F, and median spot charge Q med. and HR refer to clinical target volume and clinical target volume high risk, respectively, where the latter is the part of the receiving a boost dose. Q med ð 6 protonsþ Site Target name Target volume [cc] D T [Gy(RBE)] N fx D Rx [Gy(RBE)] N F Large Medium Small Pelvis Chest wall HR Rectum HR Chordoma Cardiac HR Retro- HR peritoneal,98.8 Spinal sarcoma Phantom Medical Physics, 44 (8), August 27
3 925 Kraan et al.: Spot charge inaccuracies in IMPT 925 Pass Rate. We defined a pass rate for the c function, 7 with tolerances of 2 mm and 2% (of prescribed dose) for per fraction results and mm and % (of global max dose) for fraction-averaged results. We considered > 95% acceptable for per fraction results, and > 99% for fraction-averaged results. We calculated for each fraction and charge error value. For each error value, we determined for the N Fx fractions the minimum, 25%, median, 75% and maximum values. The 25% values were interpolated, and we determined the value ;P and P for absolute and relative charge errors which still had an acceptable between D Fx and D Fx;i. We chose to not take the minimum Gamma value of all the fractions, because it is very subject to fluctuations and would result in an over conservative estimate of ;P and P. In a similar way, we determined the values hpi and hpi, which still have an acceptable fraction-averaged result for the mean dose (per fraction) hd Fx i compared to D Fx. Dose differences. The dose difference statistics were per fraction i: P v2t R Fx;i ¼ % ðd Fx D Fx;i Þ () N v2t D Rx and the mean over all fractions P v2t R Fx ¼ % ðd Fx hd Fx iþ (4) N v2t D Rx where N v2t was the number of voxels passing the % threshold. We consider a R Fx;i \ 5% acceptable for per fraction results, and R Fx \ 2% for fraction-averaged results.. RESULTS.A. Spot charge Table I displays the median spot charge in a fraction for all treatment plans. The median spot charge is approximately proportional to d 2 (we used d =.5r) and thus proportional to r 2. Furthermore, it is proportional to the prescribed dose, and inversely proportional to the number of fields..b. Absolute charge errors Figure gives the results of the for the perturbed plans for small spots. The black whisker plots at each simulated represent the minimum, 25%, %, 75%, and maximum (2 mm/2% tolerance) for the N Fx simulations. The 25% values, chosen as a worse-case scenario that lowers the allowable charge error, are interpolated with a smooth function, and the value ;P was determined at = 95% (dashed black line). The ( mm/% tolerance) of the mean dose matrix over all fractions is displayed in red. An interpolation with a smooth curve was done as well and the value hpi was determined at = 99% (dashed red line). Note that the different tolerances of (2%, 2 mm) and (%, mm) causes the mean dose and fraction dose curves to switch order between sites. If the Pelvis σσ CW σσ Rectum σσ CD σσ Cardiac σ = 2.5 mm, d =.5σ RP σσ Spine σσ Water σσ (g) (h) FIG.. Gamma passing rates for various patients, spot size 2.5 mm. Effects for fractional dose are displayed in black (tolerance 2%, 2 mm), and effects for fraction averaged dose (tolerance %, mm) in red. The dashed lines indicate how the value of ;P (black dashed line) and hpi (red dashed line) were determined through interpolation between simulation values of. [Color figure can be viewed at wileyonlinelibrary.com] Medical Physics, 44 (8), August 27
4 926 Kraan et al.: Spot charge inaccuracies in IMPT 926 same tolerance criteria are used, the of the mean fractional dose matrix was in all cases better than the individual fractions, so a partial cancelation of the effects occurs when considering all fractions together. We investigated the relationship between ;P and the median spot charge in the small spot plans, and found a moderate positive correlation (correlation coefficient.). A stronger correlation was found between ;P and tumor volume (correlation coefficient.8). Only weak correlations were found between hpi and median charge (correlation coefficient ) and between hpi and tumor volume (correlation coefficient 5). Absolute charge errors up to 5 6 protons were seen to have negligible impact on medium and large spot plans; in all cases we found from the values that ;P [ 5 6 protons..c. Relative charge errors We determined for small, medium, and large size spots, the value P at which 25% of the fractions had an unacceptable value, as above in Fig.. The same was done for hpi. The whisker plots for small, medium, and large size spots are displayed in Figs. 2 4, respectively. In most cases, P was smaller than hpi, demonstrating that dose effects are typically canceled when considering all fractions together. For all spot sizes together, we investigated the correlation between P and the median charge, as well as between P and the tumor volume. While a weak negative correlation was seen between P and the median charge (correlation coefficient.64), there was no correlation between P and tumor volume (correlation coefficient.). Weak negative correlations were found between hpi and median charge (correlation coefficient.6) and between hpi and tumor volume (correlation coefficient.7)..d. Charge error limits From Fig., we can estimate the maximum allowable absolute charge error in a proton accelerator providing beam sizes of 2.5 mm by looking at the minimum value of ;P and hpi. Based on the, the allowable absolute charge error for our eight patient cases is about 2 6 protons in the small spot plans, where the worse case is the chordoma case. From Table I, we can deduce that this value corresponds to about % (chordoma) to % (water phantom) of the median spot charge in their small spot treatment plans. Larger limits would be allowed if larger spots were used. The values for ;P and hpi for small spot plans for all patients are summarized in the second and third column in Table II. For relative errors, the maximum allowable error size for small, medium, and large spots can be determined by looking at the smallest value of P and hpi found in Figs. 2 4: about %, 8%, and 6% for small, medium, and large spots, respectively. The worse case is the water phantom. The values for P and hpi obtained for each patient are summarized in the fourth and fifth column of Table II for large spots, the scenario allowing smallest errors. Thus, for a machine delivering spots with variable sizes from 2.5 to mm (at isocenter in air at high energy), the required accuracy on spot charge is about 2 6 protons or 6% per spot, whichever is larger. The absolute number is based on small spots and has negligible impact on medium and large spots, and the relative number is relevant for medium and large spots and has negligible impact on small spots. If a single spot size is offered, values can be estimated from Figs. 4 by looking at the individual spot sizes. We checked the other plan statistics at the above determined charge tolerances. For absolute charge errors, the V95% was always satisfactory up to ¼ 2 6 protons. The V7% was for all patients satisfactory, apart from the chordoma case, where in one fraction it was 2% at ¼ 2 5 protons. As the fraction-averaged V7% was zero, we see that effects cancel, and we believe that an error of ¼ 2 5 can safely be tolerated. Concerning the other dose statistics, R Fx;i was below % for all fractions and all patients at an absolute charge error of 2 6 protons, and R Fx was always below %, i.e., well acceptable. For relative errors, an error of 6% had a negligible impact on all plan statistics of small and medium spot plans, demonstrating that dose distributions are not influenced by errors of this size. For large spot plans, the V95% was unmodified at e = 6%. The V7% was satisfactory for all patients apart from the chordoma patient, where we noticed that a large V7% (%) occurred at this error in single fraction. However, again the fraction-averaged V7% was zero, showing that a cancelation of hot spots takes place. Thus, we believe that a relative error of 6% can be safely tolerated..e. Dose volume histograms Concerning the DVH parameters, in Fig. 5 we display the DVHs of all patients at an absolute charge error of 2 6, for small spot plans. As mentioned above, the Chordoma patient is clearly most sensitive. This is both due to the small volume and the small spot charge, resulting from the four beam directions in a single fraction. In clinical practice, it is more common to use two beam directions per fraction in alternation. The spot charge would thus increase and the sensitivity would decrease. The sensitivity of our chordoma patient plans with small spots to the absolute error size is also demonstrated in Fig. 6. For relative charge errors, a few example DVHs are displayed in Fig. 7 for the pelvis patient. 4. DISCUSSION In the above studies, we evaluated for eight patients to what extend charge errors can modify dose distributions. Different statistics were used to quantify the dose impact. The sensitivity to charge errors turned out to be patient dependent, and correlations with tumor volume and spot charge were found. We extracted rough limits of tolerable charge errors in proton machines. Medical Physics, 44 (8), August 27
5 927 Kraan et al.: Spot charge inaccuracies in IMPT 927 Pelvis σσ CW σσ Rectum σσ CD σσ Cardiac σ σ RP σσ Spine σσ Water σσ (g) (h) FIG. 2. Gamma passing rates for various patients, spot size 2.5 mm. Effects for fractional dose are displayed in black (tolerance 2%, 2 mm), and effects for fraction averaged dose (tolerance %, mm) in red. The dashed lines indicate how the value of P (black dashed line) and hpi (red dashed line) were determined through interpolation between simulation values of e. [Color figure can be viewed at wileyonlinelibrary.com] Pelvis σ=5. mm, d=.5σ CW σ=5. mm, d=.5σ Rectum σ=5. mm, d=.5σ CD σ=5. mm, d=.5σ Cardiac σ=5. mm, d=.5σ RP σ=5. mm, d=.5σ Spine σ=5. mm, d=.5σ Water σ=5. mm, d=.5σ (g) (h) FIG.. Gamma passing rates for various patients, spot size 5 mm. Whiskers and lines as in Fig. 2. [Color figure can be viewed at wileyonlinelibrary.com] Medical Physics, 44 (8), August 27
6 928 Kraan et al.: Spot charge inaccuracies in IMPT 928 Pelvis σ=. mm, d=.5σ CW σ=. mm, d=.5σ Rectum σ=. mm, d=.5σ CD σ=. mm, d=.5σ Cardiac σ=. mm, d=.5σ RP σ=. mm, d=.5σ Spine σ=. mm, d=.5σ Water σ=. mm, d=.5σ (g) (h) FIG. 4. Gamma passing rates for various patients, spot size mm. Whiskers and lines as in Fig. 2. [Color figure can be viewed at wileyonlinelibrary.com] TABLE II. Summary of ;P, hpi, P and hpi obtained for each patient. Here ;P ð P Þ and hpi ð hpi Þ are the maximum allowed absolute (relative) charge errors determined per fraction and fraction-summed, respectively. The values for ;P and hpi are based on small spot plans, and the values for P and hpi are based on large spot plans, both representing the most conservative estimate. Site ;P ½ 6 protonsš hpi ½ 6 protonsš P ½%Š hpi ½%Š Pelvis Chest wall > 5. > Rectum > Chordoma Cardiac Retroperitoneal > > > Spinal sarcoma Phantom Absolute errors of up to 5 6 protons had a negligible impact on medium and large size spot plans. The impact on small spot plans was instead more significant, and in that case absolute charge errors should be kept below about 2 6 protons to avoid significant dose modifications, based on the chordoma case. Compared to the median spot charge for small spots plans for that case, 6:2 6 (Table I), we see that this is about %. It must be noted that 2 6 protons is only a very small fraction of the total number of protons delivered, which is :4 in this case, in about 2 spots. The impact of random relative errors was also evaluated. For small spot plans, relative errors up to % do not cause significant dose modifications. For medium and large spot plans, the relative error should stay below about 8% and 6% of the spot charge, respectively. These numbers were based on the worse case, which was the water phantom. For small spot plans, it is surprising that there are patients where even a % error does not have significant dose impact, like the retro-peritoneal and the rectum patient (Fig. 2). The reason why treatment plans are generally robust against random relative charge errors is that there is a large amount of statistical smearing naturally occurring, due to lateral and longitudinal pencil beam overlap, as well as multiple Coulomb scattering of protons in the patient. As long as errors are random, relative errors do not easily perturb the dose distributions. The numbers extracted above strongly suggest that a charge accuracy as high as %, as is commonly aimed for in circular machines, is clinically not strictly needed. For most proton machines, errors are naturally neither purely absolute nor purely relative, and a different behavior Note that when normalized to target volume, the number of delivered protons for the chordoma case is more than the general rule-ofthumb number of about protons to deliver Gy to a liter target: the target is very small and many protons are delivered in the beam penumbra. Medical Physics, 44 (8), August 27
7 929 Kraan et al.: Spot charge inaccuracies in IMPT 929 Pelvis.8 Spinal_cord Bladder R_kidney Liver CW.8 CW+IMN Lung_L esophagus thyroid_n.8 Rectum SmallBowel IliacWings Bladder IliacWings.8 CD Brain BRAINSTEM CHIASM LTOPTNRV Cardiac.8 SpinalCord Esophagus Liver Ventricles Bronchus.8 RP HighRisk SpinalCord Heart Esophagus Liver_Avg Spine.8 _Postop SpinalCord Heart_Postop Esophagus_Post.8 Water reference_cube skin 6l 6s FIG. 5. DVHs of the eight patients for small spot plans. Each thin colored line corresponding to the N Fx simulations when applying an absolute charge error of 2. 6 protons. The black solid lines are the DVHs of the nominal plan, and the black dashed lines are the DVHs corresponding to the dose of all fractions averaged. [Color figure can be viewed at wileyonlinelibrary.com].8 CD Brain BRAINSTEM CHIASM LTOPTNRV.8 CD Brain BRAINSTEM CHIASM LTOPTNRV.8 CD Brain BRAINSTEM CHIASM LTOPTNRV FIG. 6. DVHs of the chordoma patient for error sizes of :5 6, 2: 6, and 5: 6 protons. Each thin colored line corresponding to the N Fx simulations. The black solid lines are the DVHs of the nominal plan, and the black dashed lines are the DVHs corresponding to the dose of all fractions averaged. [Color figure can be viewed at wileyonlinelibrary.com] Medical Physics, 44 (8), August 27
8 9 Kraan et al.: Spot charge inaccuracies in IMPT 9 FIG. 7. Example DVHs for the pelvis patient for small (a and b), medium (c and d), and large spots (e and f), for various values of rel. The colored bands are the result of N Fx individual DVH lines. The solid line is the nominal DVHs. The dashed lines, largely overlaying with the solid lines, are the DVHs of the averaged effect over all fractions, divided by the number of fraction. The left plots all have acceptable C and the right plots have unacceptable C. [Color figure can be viewed at wileyonlinelibrary.com] Medical Physics, 44 (8), August 27
9 9 Kraan et al.: Spot charge inaccuracies in IMPT 9 may apply. To estimate the exact impact of error sources, it is very important to understand the source of charge errors, so appropriate mitigation strategies in dose delivery could be applied. If the error is mostly relative, mitigation techniques to avoid dose errors include rescanning (repeatedly scanning the tumor, or part of it) or reducing the inter-spot distance (lateral or longitudinal). The latter reduces the average spot charge, and thereby the effect of charge errors. On the other hand, if errors are mostly absolute, rescanning could lead to an unnecessary increase of dose errors, and an average spot charge should be assured that is safely above the absolute error size. Our limits were based on dose prescriptions around 2 Gy. For hypofractionation schemes, where spot charges are larger, we expect the impact of the absolute error to be even smaller. Results for relative errors are not expected to change. There are several shortcomings in this work. Absolute and relative errors were considered separately and not simultaneously. We chose to keep the results as generally applicable as possible. It would make sense to perform detailed simulations of combined effects only when the error sources are precisely knows. Moreover, the simulated charge error was random as dictated by the Gaussian function, and results probably do not apply to nonrandom errors. Furthermore, the number of patients was limited to eight. Considering a larger patient group could help in understanding better why some patients are more sensitive to charge errors than other patients, for instance by also analyzing tumor shape or depth. Only errors with sizes of up to 5 6 and % were studied and results were not extended to higher error values. The reason is that these error sizes are already large, and even larger errors seem improbable for most new-generation proton machines. Finally, our plans were IMPT plans. The effect on single field optimization plans is part of a future study. 5. CONCLUSION A potential source of errors typically not considered in treatment uncertainty studies are spot charge uncertainties. This is justified if charge errors are of the order 2%, as the effects from setup, range, and anatomical uncertainties are typically much larger (see for instance 8 ). For new-generation machines, sources to spot charge errors may be very different and much larger errors may need to be considered. In this work, we quantified the dose effect of charge errors up to % (relative error) and up to 5 6 protons (absolute error). Dose distributions turned out to be surprisingly robust against spot charge perturbation. Our study suggests that ensuring spot charge errors as small as 2% as is commonly aimed at in conventional proton therapy machines, is clinically not strictly needed. ACKNOWLEDGMENTS We thank Ugo Amaldi for valuable discussions about mitigation strategies of statistical charge errors. Furthermore, we are grateful for input from Alberto Degiovanni about pulse generation in linear accelerators. CONFLICTS OF INTEREST The authors have no conflicts of interest to disclose. a) Author to whom correspondence should be addressed. Electronic mail: Aafke.Kraan@cern.ch. REFERENCES. Gillin MT, Sahoo N, Bues M, et al. Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas M.D. Anderson Cancer Center, Proton Therapy Center, Houston. Med Phys. 2;7: Giordanengo S, Garella MA, Marchetto F. The CNAO dose delivery system for modulated scanning beam radiotherapy. Med Phys. 25; 42:26.. Amaldi U, Braccini S, Puggioni P. High frequency linacs for hadrontherapy. Rev Accelerator Sci Technol. 29;2:. 4. Kooy HM, Clasie BM, Lu H-M, et al. A case study in proton pencil beam scanning delivery. Int J Radiat Onc Biol Phys. 2;76: Hong L, Goitein M, Bucciolini M, et al. A pencil beam algorithm for proton dose calculations. Phys Med Biol. 996;4:5. 6. Chen W, Craft D, Madden TM, Kooy HM. A fast optimization algorithm for multicriteria intensity modulated proton therapy planning. Med Phys. 2;7: Clasie BM, Sharp GC, Seco J, Flanz JB, Kooy HM. Numerical solutions of the c-index in two and three dimensions. Phys Med Biol. 22;57: Kraan AC, van de Water S, Teguh DN, et al. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors. Int J Radiat Oncol Biol Phys. 2;;87: Medical Physics, 44 (8), August 27
8/3/2016. Chia-Ho, Hua St. Jude Children's Research Hospital. Kevin Teo The Hospital of the University of Pennsylvania
Bijan Arjomandy, Ph.D. Mclaren Proton Therapy Center Mark Pankuch, Ph.D. Cadence Health Proton Center Chia-Ho, Hua St. Jude Children's Research Hospital Kevin Teo The Hospital of the University of Pennsylvania
More informationParticle Beam Technology and Delivery
Particle Beam Technology and Delivery AAPM Particle Beam Therapy Symposium Types of Accelerator Systems Laser Linac Cyclotron Synchrotron Rf Linac CycFFAG FFAG CycLinac Isochronous Cyclotron Strong Focusing
More informationOutline. Physics of Charge Particle Motion. Physics of Charge Particle Motion 7/31/2014. Proton Therapy I: Basic Proton Therapy
Outline Proton Therapy I: Basic Proton Therapy Bijan Arjomandy, Ph.D. Narayan Sahoo, Ph.D. Mark Pankuch, Ph.D. Physics of charge particle motion Particle accelerators Proton interaction with matter Delivery
More informationPhysics of Novel Radiation Modalities Particles and Isotopes. Todd Pawlicki, Ph.D. UC San Diego
Physics of Novel Radiation Modalities Particles and Isotopes Todd Pawlicki, Ph.D. UC San Diego Disclosure I have no conflicts of interest to disclose. Learning Objectives Understand the physics of proton
More informationSecondary Neutron Dose Measurement for Proton Line Scanning Therapy
Original Article PROGRESS in MEDICAL PHYSICS 27(3), Sept. 2016 http://dx.doi.org/10.14316/pmp.2016.27.3.162 pissn 2508-4445, eissn 2508-4453 Secondary Neutron Dose Measurement for Proton Line Scanning
More informationMonte Carlo study of the potential reduction in out-of-field dose using a patient-specific aperture in pencil beam scanning proton therapy
University of Wollongong Research Online Faculty of Engineering - Papers (Archive) Faculty of Engineering and Information Sciences 2012 Monte Carlo study of the potential reduction in out-of-field dose
More informationLaser-Accelerated protons for radiation therapy
Laser-Accelerated protons for radiation therapy E Fourkal, I Velchev,, J Fan, J Li, T Lin, C Ma Fox Chase Cancer Center, Philadelphia, PA Motivation Proton beams provide better conformity to the treatment
More informationarxiv: v2 [physics.med-ph] 29 May 2015
The Proton Therapy Nozzles at Samsung Medical Center: A Monte Carlo Simulation Study using TOPAS Kwangzoo Chung, Jinsung Kim, Dae-Hyun Kim, Sunghwan Ahn, and Youngyih Han Department of Radiation Oncology,
More informationMonte Carlo simulations of ripple filters designed for proton and carbon ion beams in hadrontherapy with active scanning technique
Journal of Physics: Conference Series Monte Carlo simulations of ripple filters designed for proton and carbon ion beams in hadrontherapy with active scanning technique To cite this article: F Bourhaleb
More informationRadiation protection issues in proton therapy
Protons IMRT Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. Proton therapy: An overview 2. Radiation protection issues: Staff 3. Radiation
More informationUsing Prompt gamma ray emission to address uncertainties in proton therapy
Using Prompt gamma ray emission to address uncertainties in proton therapy Jerimy C. Polf, PhD, DABR Department of Radia9on Oncology University of Maryland School of Medicine AAPM 2013 Disclosures and
More informationThe effect of dose calculation uncertainty on the evaluation of radiotherapy plans
The effect of dose calculation uncertainty on the evaluation of radiotherapy plans P. J. Keall a) and J. V. Siebers Department of Radiation Oncology, Medical College of Virginia Hospitals, Virginia Commonwealth
More informationOptimization of hadron therapy proton beam using Monte Carlo code on GPU
Dottorato in Fisica degli Acceleratori, XXIX ciclo Optimization of hadron therapy proton beam using Monte Carlo code on GPU Candidata: Martina Senzacqua N matricola: 1163436 Supervisor: Prof. Vincenzo
More informationMONTE CARLO SIMULATION FOR EVALUATION OF DOSE DISTRIBUTION IN PROTON THERAPY *
Romanian Reports in Physics, Vol. 66, No. 1, P. 148 156, 2014 MONTE CARLO SIMULATION FOR EVALUATION OF DOSE DISTRIBUTION IN PROTON THERAPY * DARIUSH SARDARI, EHSAN SALIMI Department of Medical Radiation
More informationSecondary Particles Produced by Hadron Therapy
Iranian Journal of Medical Physics Vol. 12, No. 2, Spring 2015, 1-8 Received: March 10, 2015; Accepted: July 07, 2015 Original Article Secondary Particles Produced by Hadron Therapy Abdolkazem Ansarinejad
More informationTERA CONTRIBUTIONS TO PARTNER
TERA CONTRIBUTIONS TO PARTNER Ugo Amaldi University of Milano Bicocca and TERA Foundation 1 CNAO status 2 The CNAO Foundation builds with INFN in Pavia the Centre designed by TERA on the basis of PIMMS.
More informationGeant4 studies of the CNAO facility system for hadrontherapy treatment of uveal melanomas
th International Conference on Computing in High Energy and Nuclear Physics (CHEP13) IOP Publishing Journal of Physics: Conference Series 13 (1) 8 doi:1.188/17-9/13//8 Geant studies of the CNAO facility
More informationPhysics. Sunday, March 4, :30 a.m. 10:00 a.m.
Physics Sunday, March 4, 2018 9:30 a.m. 10:00 a.m. Social Q&A Use your phone, tablet, or laptop to Submit questions to speakers and moderators Answer interactive questions / audience response polls astro.org/refreshersocialqa
More informationDevelopment of beam delivery systems for proton (ion) therapy
7th 28th of July 213, JINR Dubna, Russia Development of beam delivery systems for proton (ion) therapy S t u d e n t : J o z e f B o k o r S u p e r v i s o r : D r. A l e x a n d e r M o l o k a n o v
More informationTHE mono-energetic hadron beam such as heavy-ions or
Verification of the Dose Distributions with GEANT4 Simulation for Proton Therapy T.Aso, A.Kimura, S.Tanaka, H.Yoshida, N.Kanematsu, T.Sasaki, T.Akagi Abstract The GEANT4 based simulation of an irradiation
More informationNeutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 4, NUMBER 3, SUMMER 2003 Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators David S. Followill,*
More informationNeutron Spectroscopy in Proton Therapy
Neutron Spectroscopy in Proton Therapy Khalid Aloufi Thesis submitted for the Degree of Doctor of Philosophy Department of Medical Physics and Biomedical Engineering Faculty of Engineering Sciences University
More informationProposal to convert TLS Booster for hadron accelerator
Proposal to convert TLS Booster for hadron accelerator S.Y. Lee -- Department of Physics IU, Bloomington, IN -- NSRRC Basic design TLS is made of a 50 MeV electron linac, a booster from 50 MeV to 1.5 GeV,
More informationDielectric Wall Accelerator (DWA) and Distal Edge Tracking Proton Delivery System Rock Mackie Professor Dept of Medical Physics UW Madison Co-Founder
Dielectric Wall Accelerator (DWA) and Distal Edge Tracking Proton Delivery System Rock Mackie Professor Dept of Medical Physics UW Madison Co-Founder and Chairman of the Board or TomoTherapy Inc I have
More informationElectron therapy Class 2: Review questions
Electron therapy Class 2: Review questions 1 Raphex Question: T63, 2002 In what situation is electron backscatter likely to be a problem? A. Using 1cm of tissue equivalent bolus on the skin. B. Using a
More informationBasic Radiation Physics of Protons
Basic Radiation Physics of Protons Michael Goitein Harvard Medical School and Ankerstrasse 1,5210 Windisch, Switzerland michael@goitein.ch Michael Goitein, PSI teaching course January, 2010 1 OVERVIEW
More informationFeasibility study of TULIP: a TUrning
Feasibility study of TULIP: a TUrning LInac for Protontherapy ICTR-PHE 2012 Conference 28.02.2012 A. Degiovanni U. Amaldi, M. Garlasché, K. Kraus, P. Magagnin, U. Oelfke, P. Posocco, P. Riboni, V. Rizzoglio
More informationd = Dx subject to Stochastic programming methods for
Inverse planning based on probability distributions 3 Figure 1. Prostate patient who had five CT scans before treatment. Bladder and rectum filling differs from day to day and hence the location and shape
More informationIMPROVING THE OUTCOMES OF BREAST RADIATION THERAPY: THE PRONE POSITION. Kaylyn Olson
IMPROVING THE OUTCOMES OF BREAST RADIATION THERAPY: THE PRONE POSITION Kaylyn Olson BACKGROUND Over 230,000 women will be diagnosed with breast cancer this year and approximately half of these women will
More informationA Monte Carlo Study of the Relationship between the Time. Structures of Prompt Gammas and in vivo Radiation Dose in.
A Monte Carlo Study of the Relationship between the Time Structures of Prompt Gammas and in vivo Radiation Dose in Proton Therapy Wook-Geun Shin and Chul Hee Min* Department of Radiation Convergence Engineering,
More informationBeam Optics for a Scanned Proton Beam at Loma Linda University Medical Center
Beam Optics for a Scanned Proton Beam at Loma Linda University Medical Center George Coutrakon, Jeff Hubbard, Peter Koss, Ed Sanders, Mona Panchal Loma Linda University Medical Center 11234 Anderson Street
More informationPhysics of particles. H. Paganetti PhD Massachusetts General Hospital & Harvard Medical School
Physics of particles H. Paganetti PhD Massachusetts General Hospital & Harvard Medical School Introduction Dose The ideal dose distribution ideal Dose: Energy deposited Energy/Mass Depth [J/kg] [Gy] Introduction
More informationThe volume effect of detectors in the dosimetry of small fields used in IMRT
The volume effect of detectors in the dosimetry of small fields used in IMRT Wolfram U. Laub a) Department of Medical Physics, University of Tübingen, Germany Tony Wong b) Department of Radiation Oncology,
More informationObjectives. Tolerance Limits and Action Levels for IMRT QA. The Overall Process of IMRT Planning and Delivery. Chain of IMRT Process
Tolerance Limits and Action Levels for IMRT QA Jatinder R Palta, Ph.D Siyong Kim, Ph.D. Department of Radiation Oncology University of Florida Gainesville, Florida Objectives Describe the uncertainties
More informationOutline. Indrin J. Chetty, AAPM 2006 Monte Carlo CE course. Indrin J. Chetty Henry Ford Hospital. David W. O. Rogers Carleton University
AAPM Task Group Report No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning Indrin J. Chetty Henry Ford Hospital David W. O.
More informationProton radiography with a range telescope and its use in proton therapy
Proton radiography with a range telescope and its use in proton therapy Juan L. Romero Department of Physics, University of California, Davis, CA Invited talk at Massachusetts General Hospital, Boston,
More informationCHARACTERISTICS OF DEGRADED ELECTRON BEAMS PRODUCED BY NOVAC7 IORT ACCELERATOR
ANALELE STIINTIFICE ALE UNIVERSITATII AL. I. CUZA IASI Tomul II, s. Biofizică, Fizică medicală şi Fizica mediului 2006 CHARACTERISTICS OF DEGRADED ELECTRON BEAMS PRODUCED BY NOVAC7 IORT ACCELERATOR Dan
More informationAccelerators for Hadrontherapy -- Present & Future --
IVICFA Institut Valencià d Investigació Cooperativa en Física Avançada Miniworkshop on Medical Physics Accelerators for Hadrontherapy -- Present & Future -- Silvia Verdú-Andrés TERA / IFIC (CSIC-UV) Valencia,
More informationHeuijin Lim, Manwoo Lee, Jungyu Yi, Sang Koo Kang, Me Young Kim, Dong Hyeok Jeong
Original Article PMP Progress in Medical Physics 28(2), June 2017 https://doi.org/10.14316/pmp.2017.28.2.49 pissn 2508-4445, eissn 2508-4453 Electron Energy Distribution for a Research Electron LINAC Heuijin
More informationFitting the Bragg peak for accurate proton range determination
Fitting the Bragg peak for accurate proton range determination Koen Lambrechts July 10, 2015 Abstract This paper focusses on the uncertainties in proton range determination in the framework of optimizing
More informationPencil beam scanning proton therapy: the significance of secondary particles
University of Wollongong Research Online University of Wollongong Thesis Collection University of Wollongong Thesis Collections 2011 Pencil beam scanning proton therapy: the significance of secondary particles
More informationIsotope Production for Nuclear Medicine
Isotope Production for Nuclear Medicine Eva Birnbaum Isotope Program Manager February 26 th, 2016 LA-UR-16-21119 Isotopes for Nuclear Medicine More than 20 million nuclear medicine procedures are performed
More informationMeasurements of secondary particles emitted by 12 C, 4 He and 16 O ion beams in view of innovative dose profiling technique in Particle Therapy
Measurements of secondary particles emitted by C, 4 He and 16 O ion beams in view of innovative dose profiling technique in Particle Therapy A. Rucinski b,d, G. Battistoni g, F. Collamati a,b, E. De Lucia
More informationSimulation Modeling in Dosimetry
Simulation Modeling in Dosimetry Aleksei Zhdanov Ural Federal University named after the first President of Russia B. N. Yeltsin, Yekaterinburg, Russian Federation jjj1994@yandex.ru Leonid Dorosinskiy
More informationUnconventional Acceleration Systems for Proton Radiotherapy
Unconventional Acceleration Systems for Proton Radiotherapy Thomas Rockwell Mackie Emeritus Professor University of Wisconsin Director of Medical Devices Morgridge Institute for Research Madison WI Conflict
More informationOverview and Status of the Austrian Particle Therapy Facility MedAustron. Peter Urschütz
Overview and Status of the Austrian Particle Therapy Facility MedAustron Peter Urschütz MedAustron Centre for ion beam therapy and non-clinical research Treatment of 1200 patients/year in full operation
More informationTowards Proton Computed Tomography
SCIPP Towards Proton Computed Tomography L. R. Johnson, B. Keeney, G. Ross, H. F.-W. Sadrozinski, A. Seiden, D.C. Williams, L. Zhang Santa Cruz Institute for Particle Physics, UC Santa Cruz, CA 95064 V.
More informationIl picco di Bragg. G. Battistoni INFN Milano. 08/06/2015 G. Battistoni
Il picco di Bragg G. Battistoni INFN Milano 08/06/015 G. Battistoni 1 Φ(z) The physics of Bragg Peak 180 MeV proton in water Longitudinal profile: Transversel profile: Φ(z,x) dominated by interaction with
More informationInitial Studies in Proton Computed Tomography
SCIPP Initial Studies in Proton Computed Tomography L. R. Johnson, B. Keeney, G. Ross, H. F.-W. Sadrozinski, A. Seiden, D.C. Williams, L. Zhang Santa Cruz Institute for Particle Physics, UC Santa Cruz,
More informationResearch Physicist Field of Nuclear physics and Detector physics. Developing detector for radiation fields around particle accelerators using:
Christopher Cassell Research Physicist Field of Nuclear physics and Detector physics Developing detector for radiation fields around particle accelerators using: Experimental data Geant4 Monte Carlo Simulations
More informationTowards efficient and accurate particle transport simulation in medical applications
Towards efficient and accurate particle transport simulation in medical applications L. Grzanka1,2, M. Kłodowska1, N. Mojżeszek1, N. Bassler3 1 Cyclotron Centre Bronowice, Institute of Nuclear Physics
More informationEffective Treatment Planning with Imperfect Models and Uncertain Biological Parameters
Effective Treatment Planning with Imperfect Models and Uncertain Biological Parameters ob Stewart, Ph.. Associate Professor and Assistant Head of Health Sciences irector, adiological Health Science Program
More informationA comparison of methods for monitoring photon beam energy constancy
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 6, 2016 A comparison of methods for monitoring photon beam energy constancy Song Gao, 1a Peter A. Balter, 1 Mark Rose, 2 and William E. Simon
More informationAdvanced Linac Solutions for Hadrontherapy
Workshop on Innovative Delivery Systems in Particle Therapy Torino, 23-24 th February 2017 Advanced Linac Solutions for Hadrontherapy A. Garonna on behalf of Prof. U. Amaldi V. Bencini, D. Bergesio, D.
More informationLatest developments in PET verification of proton therapy
Latest developments in PET verification of proton therapy Katia Parodi, Ph.D. Heidelberg Ion Therapy Centre, Heidelberg, Germany Previously: Massachusetts General Hospital and Harvard Medical School, Boston,
More informationThe Radiological Physics Center s standard dataset for small field size output factors
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 13, NUMBER 5, 2012 The Radiological Physics Center s standard dataset for small field size output factors David S. Followill, 1a Stephen F. Kry, 1 Lihong
More informationA study of monitoring performances with the INSIDE system. Francesco Pennazio on behalf of the INSIDE collaboration
A study of monitoring performances with the INSIDE system Francesco Pennazio on behalf of the INSIDE collaboration INSIDE Hadrontherapy monitoring system TRACKER PET heads Courtesy of G. Giraudo 2 INSIDE
More informationComparison of two commercial detector arrays for IMRT quality assurance
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 10, NUMBER 2, SPRING 2009 Comparison of two commercial detector arrays for IMRT quality assurance Jonathan G. Li, 1,a Guanghua Yan, 1,2 and Chihray Liu
More informationEstimate of Photonuclear Reaction in a Medical Linear Accelerator Using a Water-Equivalent Phantom
Progress in NUCLEAR SCIENCE and TECHNOLOGY, Vol. 2, pp.83-87 (2) ARTICLE Estimate of Photonuclear Reaction in a Medical Linear Accelerator Using a Water-Equivalent Phantom Toshioh FUJIBUCHI,2,*, Satoshi
More informationROC7080: RADIATION THERAPY PHYSICS LABORATORY LAB A : MECHANICAL MEASUREMENTS LINAC QA
ROC7080: RADIATION THERAPY PHYSICS LABORATORY LAB A : MECHANICAL MEASUREMENTS LINAC QA GROUP I SPRING 2014 KEVIN JORDAN GRADUATE STUDENT, RADIOLOGICAL PHYSICS KARMANOS CANCER CENTER WAYNE STATE UNIVERSITY
More informationTime-resolved beam symmetry measurement for VMAT commissioning and quality assurance
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 17, NUMBER 2, 2016 Time-resolved beam symmetry measurement for VMAT commissioning and quality assurance Michael P. Barnes 1,2 a and Peter B. Greer 1,3
More informationEvaluation of an electron Monte Carlo dose calculation algorithm for electron beams
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 9, NUMBER 3, SUMMER 2008 Evaluation of an electron Monte Carlo dose calculation algorithm for electron beams Ye Angela Hu, 1,a Haijun Song, 2 Zhe Chen,
More informationOptimal fractionation in radiotherapy with multiple normal tissues
Optimal fractionation in radiotherapy with multiple normal tissues Fatemeh Saberian, Archis Ghate, and Minsun Kim May 16, 2015 Abstract The goal in radiotherapy is to maximize the biological effect of
More informationACCELERATORS AND MEDICAL PHYSICS 3
ACCELERATORS AND MEDICAL PHYSICS 3 Ugo Amaldi University of Milano Bicocca and TERA Foundation 1 People of hadrontherapy Other uses: hadron therapy BUT radiotherapy is a single word particlle therapy BUT
More informationParticle accelerators. Dr. Alessandro Cianchi
Particle accelerators Dr. Alessandro Cianchi Particle accelerators: instructions 48 hrs lectures (Wednesday 6, Friday 6 9:00) All the documentation is available via web in pdf @ http://people.roma2.infn.it/~cianchi/didattica.html
More informationModelling of a proton spot scanning system using MCNP6
Home Search Collections Journals About Contact us My IOPscience Modelling of a proton spot scanning system using MCNP6 This content has been downloaded from IOPscience. Please scroll down to see the full
More informationMonte Carlo Simulation concerning Particle Therapy
Monte Carlo Simulation concerning Particle Therapy Masaaki Takashina Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan INTRODUCTION It is well known that the particle therapy has some
More informationHadron Therapy Medical Applications
Hadron Therapy Medical Applications G.A. Pablo Cirrone On behalf of the CATANA GEANT4 Collaboration Qualified Medical Physicist and PhD Student University of Catania and Laboratori Nazionali del Sud -
More informationEngines of Discovery
http://www.enginesofdiscovery.com/ Synchrotron Light Sources Spring 8, a synchrotron light source located in Japan. This intricate structure of a complex protein molecule structure has been determined
More informationDynamic robust optimization for fractionated IMRT treatment planning
Dynamic robust optimization for fractionated IMRT treatment planning Velibor V. Mišić Timothy C.Y. Chan Department of Mechanical and Industrial Engineering, University of Toronto June 20, 2011 INFORMS
More informationAbsorption spectra variations of EBT radiochromic film from radiation exposure
INSTITUTE OF PHYSICS PUBLISHING Phys. Med. Biol. 5 (25) N35 N4 PHYSICS IN MEDICINE AND BIOLOGY doi:.88/3-955/5/3/n2 NOTE Absorption spectra variations of EBT radiochromic film from radiation exposure M
More information8/3/2016. Challenges and opportunities for implementing biological optimization in particle therapy. Overview of Talk
Challenges and opportunities for implementing biological optimization in particle therapy David J. Carlson, Ph.D. Associate Professor Dept. of Therapeutic Radiology david.j.carlson@yale.edu 58 th Annual
More informationMarkus Roth TU Darmstadt
Laser-driven Production of Particle Beams and their application to medical treatment Markus Roth TU Darmstadt The Case Laser-driven electrons Potential for Applications in Therapy Use of secondary Radiation
More informationDesign of a proton therapy synchrotron. A Dosage Calculation Example
Design of a proton therapy synchrotron S.Y. Lee, Indiana University Introduction Accelerator concepts: Cyclotron vs synchrotron, etc. Design issues Beam delivery issues Conclusion Some Proton Therapy Facilities
More informationUse of a radioactive check device for redundancy check of ionization chambers
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 1, NUMBER 4, FALL 2000 Use of a radioactive check device for redundancy check of ionization chambers N. P. S. Sidhu,* Alkis Rouvas, and Patrick Cadman
More informationAnalysis of Carbon Ion Fragmentation and Angular Fragment Distributions using a flexible set-up
Analysis of Carbon Ion Fragmentation and Angular Fragment Distributions using a flexible set-up G. Arico1,2, B. Hartmann2, J. Jakubek3, S. Pospisil3, O. Jäkel1,2,4, M. Martisikova1,2 1 University Clinic
More informationNuclear Physics and Astrophysics
Nuclear Physics and Astrophysics PHY-302 Dr. E. Rizvi Lecture 24 Medical Imaging Effects of Radiation We now know what radiation is But what does it mean for our bodies? Radioactivity is quantified in
More informationShielding verification and neutron dose evaluation of the Mevion S250 proton therapy unit
Received: 12 September 2017 Revised: 14 November 2017 Accepted: 22 November 2017 DOI: 10.1002/acm2.12256 RADIATION PROTECTION & REGULATIONS Shielding verification and neutron dose evaluation of the Mevion
More informationassuming continuous slowing down approximation , full width at half maximum (FWHM), W 80 20
Special Edition 408 Depth Dose Characteristics of Proton Beams within Therapeutic Energy Range Using the Particle Therapy Simulation Framework (PTSim) Monte Carlo Technique Siou Yin Cai 1, Tsi Chain Chao
More informationPre-report on the dissertation Development of a treatment verification system for continuous scanning in proton therapy
Research Collection Report Pre-report on the dissertation Development of a treatment verification system for continuous scanning in proton therapy Author(s): Klimpki, Grischa Publication Date: 2015 Permanent
More informationTHE UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER GRADUATE COLLEGE MONTE CARLO SIMULATION FOR THE MEVION S250 PROTON THERAPY SYSTEM: A TOPAS STUDY
THE UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER GRADUATE COLLEGE MONTE CARLO SIMULATION FOR THE MEVION S250 PROTON THERAPY SYSTEM: A TOPAS STUDY A DISSERTATION SUBMITTED TO THE GRADUATE FACULTY in partial
More informationQuality-Assurance Check of Collimator and Phantom- Scatter Factors
Quality-Assurance Check of Collimator and Phantom- Scatter Factors Ramesh C. Tailor, David S. Followill, Nadia Hernandez, Timothy S. Zhu, and Geoffrey S. Ibbott. UT MD Anderson Cancer Center, Houston TX.
More informationUtilizing IMRT Intensity Map Complexity Measures in Segmentation Algorithms. Multileaf Collimator (MLC) IMRT: Beamlet Intensity Matrices
Radiation Teletherapy Goals Utilizing IMRT Intensity Map Complexity Measures in Segmentation Algorithms Kelly Sorensen August 20, 2005 Supported with NSF Grant DMI-0400294 High Level Goals: Achieve prescribed
More informationStudy of the influence of phantom material and size on the calibration of ionization chambers in terms of absorbed dose to water
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 7, NUMBER 3, SUMMER 2006 Study of the influence of phantom material and size on the calibration of ionization chambers in terms of absorbed dose to water
More informationPARTICLE RELATIVE MASS RELATIVE CHARGE. proton 1 +1
Q1. (a) Atoms are made up of three types of particle called protons, neutrons and electrons. Complete the table below to show the relative mass and charge of a neutron and an electron. The relative mass
More informationReference Dosimetry for Megavoltage Therapy Beams: Electrons
Reference Dosimetry for Megavoltage Therapy Beams: Electrons David Followill Ph.D Radiological Physics Center UT M.D.Anderson Cancer Center Houston TX Protocol for Clinical Reference Dosimetry of High-Energy
More informationSimulations in Radiation Therapy
Simulations in Radiation Therapy D. Sarrut Directeur de recherche CNRS Université de Lyon, France CREATIS-CNRS ; IPNL-CNRS ; Centre Léon Bérard Numerical simulations and random processes treat cancer 2
More informationACCELERATORS AND MEDICAL PHYSICS
ACCELERATORS AND MEDICAL PHYSICS 1 Ugo Amaldi University of Milano Bicocca and TERA Foundation EPFL 1-28.10.10 - U. Amaldi 1 Short history of Medical Physics with radiations (*) In physics radiation is
More informationFuture (of )Synchrotrons for Particle Therapy. Jay Flanz. Where are we now? Where do we need to go?
Future (of )Synchrotrons for Particle Therapy Where are we now? Where do we need to go? Jay Flanz Technical Director, Burr Proton Therapy Center Assoc. Prof. Harvard Medical School Berkeley: Start of Particle
More informationEvaluation of the truebeam machine performance check (MPC): mechanical and collimation checks
Received: 5 December 2016 Revised: 30 January 2017 Accepted: 14 February 2017 DOI: 10.1002/acm2.12072 RADIATION ONCOLOGY PHYSICS Evaluation of the truebeam machine performance check (MPC): mechanical and
More informationActivation of Implanted Gold Markers in Therapeutic Proton Beams. J. J. Wilkens. Northeast Proton Therapy Center Report Number
Activation of Implanted Gold Markers in Therapeutic Proton Beams J. J. Wilkens Northeast Proton Therapy Center Report Number 2004-01 January 2004 Activation of implanted gold markers in therapeutic proton
More informationVolume 1 No. 4, October 2011 ISSN International Journal of Science and Technology IJST Journal. All rights reserved
Assessment Of The Effectiveness Of Collimation Of Cs 137 Panoramic Beam On Tld Calibration Using A Constructed Lead Block Collimator And An ICRU Slab Phantom At SSDL In Ghana. C.C. Arwui 1, P. Deatanyah
More informationResponse characteristics of an imaging plate to clinical proton beams
Nuclear Instruments and Methods in Physics Research A 424 (1999) 569 574 Response characteristics of an imaging plate to clinical proton beams A. Nohtomi *, T. Terunuma, R. Kohno, Y. Takada, Y. Hayakawa,
More informationIn our recent paper [1], applicability of the self-activation of an NaI scintillator has been studied for the photo-neutron monitoring around
Proc. Int. Symp. on Radiation Detectors and Their Uses (ISRD2016) https://doi.org/10.7566/jpscp.11.050002 High Sensitive Neutron-detection by using a Self-activation of Iodine-containing Scintillators
More informationImplementation of the IAEA-AAPM Code of Practice for the dosimetry of small static fields used in external beam radiotherapy
Implementation of the IAEA-AAPM Code of Practice for the dosimetry of small static fields used in external beam radiotherapy M. Saiful Huq, PhD, FAAPM, FInstP Dept. of Radiation Oncology, University of
More informationIonizing Radiation Dosimetry and Medical Physics
Ionizing Radiation Dosimetry and Medical Physics D.W.O. Rogers Ionizing Radiation Standards, Institute for National Measurement Standards NRC, Ottawa, K1A OR6 Present e-mail: drogers at physics.carleton.ca
More information1 Introduction. A Monte Carlo study
Current Directions in Biomedical Engineering 2017; 3(2): 281 285 Sebastian Richter*, Stefan Pojtinger, David Mönnich, Oliver S. Dohm, and Daniela Thorwarth Influence of a transverse magnetic field on the
More informationCOMPARISON OF COMPUTER CODES APPLICABILITY IN SHIELDING DESIGN FOR HADRON THERAPY FACILITIES *
Romanian Reports in Physics, Vol. 66, No. 1, P. 142 147, 2014 COMPARISON OF COMPUTER CODES APPLICABILITY IN SHIELDING DESIGN FOR HADRON THERAPY FACILITIES * D. SARDARI, M. HAMEDINEJAD Islamic Azad University,
More informationIRPA 2 nd European Congress, Paris, May Session: RP in Medicine - Workers. Activation Products In Medical Linear Accelerators
IRPA 2 nd European Congress, Paris, May 15-19 2006 Session: RP in Medicine - Workers Activation Products In Medical Linear Accelerators FISCHER Helmut W.*, TABOT Ben*,+, POPPE, Björn + * University of
More informationOPTIMIZATION OF COMPENSATION CHICANES IN THE LCLS-II BEAM DELIVERY SYSTEM
OPTIMIZATION OF COMPENSATION CHICANES IN THE LCLS-II BEAM DELIVERY SYSTEM LCLS-II TN-15-41 11/23/2015 J. Qiang, M. Venturini November 23, 2015 LCLSII-TN-15-41 1 Introduction L C L S - I I T E C H N I C
More information